Bildkälla: Stockfoto

Ovzon: Sales starting to return to pre-COVID levels - ABG

Sales of SEK 48m, +44% q-o-q and 3% above ABGSCe
Small estimate changes for ‘22e-‘23e
8x EV/EBIT on ‘23e, and 5x EV/EBIT on ‘24e

After five consecutive quarters with declining sales in y-o-y terms, Ovzon reported Q3 sales of SEK 48m, corresponding to 48% y-o-y and +3% vs. ABGSCe. Sequentially, this represented growth of 44%, driven by recent order announcements: both services orders and product orders (for its T6 terminal). As such, utilisation is gradually improving, but is still below historical levels as suggested by the Q3 gross margin of 16% (vs. 46% on avg. for Q1’17-Q1’20). Although opex was flat y-o-y (-5% vs. ABGSCe), the currently muted gross margin led to EBIT of SEK -23m (vs. SEK -17m in Q3’20).

In Q3, Ovzon completed a directed share issue, which gave gross proceeds of SEK 238m (9% dilution). The share issue strengthens its balance sheet and thereby gives further headroom if the launch of Ovzon-3 does incur further delays. The launch is set to occur in Q2’22, and although we acknowledge that there are several moving parts – mainly related to the global supply chain issues – we understand that the project is in its final stage and we are therefore positive regarding the likelihood that the satellite will go into orbit during the set launch window.
Börsvärldens nyhetsbrev
ANNONSER